Methods of assessment of urogenital atrophy and the implication of these in estimated prevalence rates: A review of the literature.

Q3 Medicine

Post reproductive health Pub Date : 2023-09-01 DOI:10.1177/20533691231199803

Paula Briggs, Rachel Burton, Chiara Mosely, Imogen Sharp, Fayosola Mercy, Gayathri Delanerolle, Dharani K Hapangama

{"title":"Methods of assessment of urogenital atrophy and the implication of these in estimated prevalence rates: A review of the literature.","authors":"Paula Briggs, Rachel Burton, Chiara Mosely, Imogen Sharp, Fayosola Mercy, Gayathri Delanerolle, Dharani K Hapangama","doi":"10.1177/20533691231199803","DOIUrl":null,"url":null,"abstract":"Background: Urogenital atrophy is caused by lack of estrogen, most commonly due to the menopause. Symptoms frequently experienced include vaginal dryness, itching, burning, sexual difficulties and urinary problems, all of which can have a significant adverse effect on quality of life. Effective treatments are available for women with a confirmed diagnosis. The aim of this review is to determine whether a consistent diagnostic intervention exists, to support an accurate indication of prevalence.Materials and methods: This study is a review of the literature.Results: A total of 1469 papers were identified on an initial search, including randomised controlled trials, cross sectional and cohort studies. By adoption of a systematic process, the number of papers in the final review was eight.There is inconsistent use of available assessment methods to diagnose urogenital atrophy in symptomatic women. There are no validated clinical assessment tools.Conclusion: Absence of a defined intervention with which to confirm a diagnosis of urogenital atrophy, based on symptoms, influences research outcomes, but more importantly affects access to an accurate diagnosis and treatment, for affected women. This would ideally take place in a primary care setting.","PeriodicalId":52104,"journal":{"name":"Post reproductive health","volume":"29 3","pages":"135-142"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Post reproductive health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/20533691231199803","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Urogenital atrophy is caused by lack of estrogen, most commonly due to the menopause. Symptoms frequently experienced include vaginal dryness, itching, burning, sexual difficulties and urinary problems, all of which can have a significant adverse effect on quality of life. Effective treatments are available for women with a confirmed diagnosis. The aim of this review is to determine whether a consistent diagnostic intervention exists, to support an accurate indication of prevalence.

Materials and methods: This study is a review of the literature.

Results: A total of 1469 papers were identified on an initial search, including randomised controlled trials, cross sectional and cohort studies. By adoption of a systematic process, the number of papers in the final review was eight.There is inconsistent use of available assessment methods to diagnose urogenital atrophy in symptomatic women. There are no validated clinical assessment tools.

Conclusion: Absence of a defined intervention with which to confirm a diagnosis of urogenital atrophy, based on symptoms, influences research outcomes, but more importantly affects access to an accurate diagnosis and treatment, for affected women. This would ideally take place in a primary care setting.

查看原文本刊更多论文

评估泌尿生殖器萎缩的方法及其在估计患病率中的意义:文献综述。

背景:泌尿生殖器萎缩是由雌激素缺乏引起的，最常见的原因是更年期。经常出现的症状包括阴道干燥、瘙痒、灼烧、性困难和泌尿系统问题，所有这些都可能对生活质量产生重大不利影响。确诊的女性可以得到有效的治疗。本综述的目的是确定是否存在一致的诊断干预措施，以支持准确的患病率指示。材料与方法:本研究为文献综述。结果:在最初的检索中，共确定了1469篇论文，包括随机对照试验、横断面和队列研究。通过采用系统化的流程，最终评审的论文数量为8篇。有不一致的使用现有的评估方法来诊断有症状的妇女的泌尿生殖器萎缩。没有有效的临床评估工具。结论:缺乏明确的干预措施，根据症状确认泌尿生殖萎缩的诊断，影响研究结果，但更重要的是影响受影响妇女获得准确诊断和治疗的机会。理想情况下，这将在初级保健环境中进行。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Post reproductive health Medicine-Obstetrics and Gynecology

CiteScore

2.50

自引率

0.00%

发文量

期刊介绍： Post Reproductive Health (formerly Menopause International) is a MEDLINE indexed, peer reviewed source of news, research and opinion. Aimed at all those involved in the field of post reproductive health study and treatment, it is a vital resource for all practitioners and researchers. As the official journal of the British Menopause Society (BMS), Post Reproductive Health has a broad scope, tackling all the issues in this field, including the current controversies surrounding postmenopausal health and an ageing and expanding female population. Initially this journal will concentrate on the key areas of menopause, sexual health, urogynaecology, metabolic bone disease, cancer diagnosis and treatment, recovering from cancer, cardiovascular disease, cognition, prescribing, use of new hormone therapies, psychology, the science of ageing, sociology, economics, and quality of life. However as a progressive and innovative journal the Editors are always willing to consider other areas relevant to this rapidly expanding area of healthcare.